SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 24 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | 0.0% | 1,674 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -60.0% | 1,674 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -44.4% | 1,674 | 0.0% | 0.00% | – |
| Q3 2021 | $18,000 | +200.0% | 1,674 | +182.3% | 0.00% | – |
| Q2 2021 | $6,000 | -40.0% | 593 | -17.3% | 0.00% | – |
| Q1 2021 | $10,000 | – | 717 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpha Wave Global, LP | 213,658 | $3,104,000 | 0.19% |
| Serengeti Asset Management LP | 20,000 | $291,000 | 0.13% |
| FORMULA GROWTH LTD | 56,276 | $818,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 375,000 | $5,449,000 | 0.12% |
| TUDOR INVESTMENT CORP ET AL | 113,353 | $1,647,000 | 0.03% |
| Duquesne Family Office | 100,000 | $1,453,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 67,357 | $941,000 | 0.03% |
| MOORE CAPITAL MANAGEMENT, LP | 127,500 | $1,853,000 | 0.02% |
| Zimmer Partners, LP | 46,000 | $668,000 | 0.01% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 26,000 | $376,000 | 0.00% |